Login
Navigate Fool.com
Will SVA beat
the market?

Sinovac Biotech Ltd. (NASDAQ: SVA)

Community Rating: 2 Stars: Unattractive

5.55 -0.16 (-2.80%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.65
Previous Close $5.71
Daily Range $5.51 - $5.66
52-Week Range $3.85 - $8.14
Market Cap $308.4M
P/E Ratio 43.92
Dividend (Yield) $0.00 (0.0%)
Volume 67,397
Average Daily Volume 187,878
Current FY EPS -$0.06

How do you think SVA
will perform against the market?

Top SVA Bull/Bear Pitches

 

zzlangerhans (< 20)
Submitted July 23, 2013

Sinovac has been grinding out growth in YoY vaccine revenues while limiting their cash burn and achieving acceptance of their regulatory application for the EV71 hand-foot-mouth disease vaccine in Chi … More

0 Replies Reply Report this Post
 

TMFBreakerBrian (< 20)
Submitted June 10, 2008

Any company garnering a positive rating from Dutton Associates should set off all sorts of warning bells to investors.

1 Replies Reply Report this Post

News & Commentary Rss Feed

Monday’s Top Biotech Stories: Allergan, Anacor, and Sinovac Biotech

Allergan, Anacor, and Sinovac are the top health care stocks to watch this Monday morning.

Why Sinovac Biotech, Burlington Stores, and ZIOPHARM Oncology Are Today's 3 Best Stocks

The S&P makes up nearly all of yesterday's lost ground, while Sinovac, Burlington, and ZIOPHARM all rise by double digits.

Healthcare Stocks Pulling Out From Earlier Skid; Sinovac Biotech Climbs to 3-Year High After Q4 EPS

Healthcare Stocks Pulling Out From Earlier Skid; Sinovac Biotech Climbs to 3-Year High After Q4 EPS Beat

Sector Update: Healthcare

Healthcare Stocks Nudge Higher; Sinovac Biotech Up 4% After Virus Vaccine Succeeds in Late-Stage Tes

Healthcare Stocks Nudge Higher; Sinovac Biotech Up 4% After Virus Vaccine Succeeds in Late-Stage Testing

Sector Update: Healthcare

Why Sinovac, Pluristem, and Synta Could Be Worth Watching Today

Sinovac, Pluristem, and Synta Pharmaceuticals might all be worth a look today. Let's take a look at the headlines that could move these three stocks.

Sector Update: Healthcare Shares Lower; Sinovac Surges 10% on Q3 Results

Sector Update: Healthcare

Why Sinovac Biotech Ltd. Shares Spiked Higher

Sinovac puts a thumping on the lone Wall Street earnings estimate in the second quarter, but are shares now overvalued?

See More SVA News...

Sector

Healthcare

Industry

Drugs

Sinovac Biotech Ltd. (SVA) Description

A biopharmaceutical company which is in the business of research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases. Website: http://www.sinovac.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks